胞外CypB抑制p53通路促进胶质母细胞瘤适应谷氨酰胺剥夺微环境的机制研究
批准号:
82060455
项目类别:
地区科学基金项目
资助金额:
31.0 万元
负责人:
潘亚文
依托单位:
学科分类:
肿瘤代谢
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
潘亚文
中文摘要
胶质母细胞瘤(GBM)增殖过程中依赖谷氨酰胺(Gln)代谢。而血管生成滞后造成GBM核心区域Gln缺失。尚不清楚GBM适应Gln剥夺微环境的机制。前期发现Gln剥夺微环境诱导GBM细胞分泌CypB,而胞外CypB降低氧化磷酸化,促进葡萄糖摄取和乳酸转化。基于此,我们推测胞外CypB通过控制糖酵解和线粒体氧化磷酸化之间的代谢平衡增强乳酸分泌,而高乳酸促进GBM适应Gln剥夺微环境。为了验证该假设,本项目将基于基因敲除细胞、转基因斑马鱼和裸鼠原位移植瘤模型,采用细胞能量检测、小动物活体成像和时间延迟成像等技术分析胞外CypB抑制p53通路对GBM细胞糖酵解和线粒体氧化磷酸化的调控作用。构建体内外高乳酸环境,分析高乳酸对GBM适应Gln剥夺微环境的影响。基于Gln感受器,观察Gln时空变化对GBM增殖的影响及分析CypB的调控作用。本项目有望为GBM难治性和耐药性提供潜在治疗靶点和理论依据。
英文摘要
The proliferation of glioblastoma (GBM) depends heavily on glutamine (Gln) metabolism. However, the lag of angiogenesis results in the extreme loss of Gln in the core area of GBM. It is not clear how GBM can maintain its growth in this microenvironment. It was found that Gln deprivation induced GBM cells to secrete CypB. Extracellular CypB promotes glucose uptake and lactate transformation, resulting in increased mitochondrial fragments and decreased membrane potential. Based on this, we speculated that extracellular CypB could promote GBM adapts to Gln deprivation microenvironment by controlling the metabolic balance between glycolysis and mitochondrial oxidative phosphorylation,promoting GBM to adapt to Gln deprivation microenvironment by enhancing lactate secretion..In order to test the hypothesis, based on the model of knockout cells, transgenic zebrafish and orthotopic transplanted tumor in nude mice, the project will use cell energy analysis, live imaging of small animals and time delay imaging to analyze the effect of extracellular CypB on GBM glycolysis and mitochondrial oxidative phosphorylation, and clarify the regulatory effect of extracellular CypB on p53 pathway. The effects of high lactate on the adaptation of GBM to the Gln deprivation microenvironment were studied by constructing a high lactate environment in vitro and in vivo. Based on Gln receptor, time-delay imaging technology was used to visually observe the influence of Gln time-space changes on GBM proliferation and analyze the role of CypB. This project is expected to provide potential therapeutic targets and theoretical basis for GBM.
胶质母细胞瘤(Glioblastoma,GBM)是最致命和最具侵袭性的WHO 4级星形细胞瘤。由于GBM核心区域处于缺氧及营养缺乏等高度异质微环境,新生血管生成速度滞后,无法将循环系统中的Gln通过血管及时运输到该区域,导致肿瘤内部的Gln被大量消耗。因此,本项目的目的就是探讨GBM究竟是如何适应这种Gln剥夺微环境。PI3K/AKT信号通路调节多种细胞活动包括细胞存活,增殖,代谢和癌症进展。PI3K/AKT/HIF-1α通路与糖酵解、线粒体动力学紊乱密切相关。我们通过String网站预测了CypB、CD147、HIF-1α、DRP1与PI3K/AKT的关系,发现CypB/CD147可以直接作用到AKT,并与HIF-1α及DRP1产生联系,而与PI3K并无关联。本项研究中,我们不仅构建了敲减si-CD147模型验证CD147对AKT的影响,还通过CO-IP证实CD147与AKT存在互作关系。加入AKT抑制剂MK2206,HIF-1α呈下调表达,同时DRP1的抑制也会影响ND1的表达。总之,GBM的核心区域处于Gln剥夺微环境,而核心区域的肿瘤细胞为了满足生长的需要,必须要适应这种不利的生长环境。我们的数据表明,Gln剥夺的微环境中,GSH水平较低,ROS产生增多,使ER出现应激,导致位于ER的CypB分泌到细胞外;而胞外CypB可以与其细胞膜上的受体CD147结合,激活p-AKT,上调HIF-1α的表达进而影响GLUT1和LDHA增强糖酵解;另一方面,p-AKT上调DRP1表达,线粒体分裂增加,通过影响线粒体呼吸链复合物Ⅰ抑制线粒体功能,进一步增强有氧糖酵解以适应Gln剥夺微环境。本项目的实施揭示了GBM适应Gln剥夺微环境的机制,为靶向调控Gln代谢治疗GBM提供了理论依据。
NF1基因突变增加胶质母细胞瘤对PARP1抑制剂化疗敏感性的机制研究
-
批准号:82360566
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:潘亚文
-
依托单位:
国内基金
海外基金